share_log

Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.65%),Deep Track Biotechnology Master Fund, Ltd.(9.65%), etc.

内克塔治疗 | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(9.65%),Deep Track Biotechnology Master Fund, Ltd.(9.65%)等

SEC announcement ·  02/14 08:58
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息